These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3117830)

  • 1. Evidence of thyrotropin-releasing hormone (TRH) and TRH-binding sites in human nonsecreting pituitary adenomas.
    Le Dafniet M; Grouselle D; Li JY; Kujas M; Bression D; Barret A; Tixier-Vidal A; Peillon F
    J Clin Endocrinol Metab; 1987 Nov; 65(5):1014-9. PubMed ID: 3117830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of receptors for thyrotropin-releasing hormone in human prolactin-secreting adenomas.
    Le Dafniet M; Brandi AM; Bression D; Racadot T; Peillon F
    J Clin Endocrinol Metab; 1983 Aug; 57(2):425-7. PubMed ID: 6306043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered balance between thyrotropin-releasing hormone and dopamine in prolactinomas and other pituitary tumors compared to normal pituitaries.
    Le Dafniet M; Blumberg-Tick J; Gozlan H; Barret A; Joubert Bression D; Peillon F
    J Clin Endocrinol Metab; 1989 Aug; 69(2):267-71. PubMed ID: 2502552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of receptors for thyrotropin (TSH)-releasing hormone in human TSH-secreting pituitary adenomas associated with hyperthyroidism.
    Chanson P; Li JY; Le Dafniet M; Derome P; Kujas M; Murat A; Charpentier G; Racadot J; Peillon F
    J Clin Endocrinol Metab; 1988 Feb; 66(2):447-50. PubMed ID: 2828411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal and adenomatous human pituitaries secrete thyrotropin-releasing hormone in vitro: modulation by dopamine, haloperidol, and somatostatin.
    Le Dafniet M; Lefebvre P; Barret A; Mechain C; Feinstein MC; Brandi AM; Peillon F
    J Clin Endocrinol Metab; 1990 Aug; 71(2):480-6. PubMed ID: 1974264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyrotropin-releasing hormone (TRH) binding sites and thyrotropin response to TRH are regulated by thyroid hormones in human thyrotropic adenomas.
    Le Dafniet M; Brandi AM; Kujas M; Chanson P; Peillon F
    Eur J Endocrinol; 1994 Jun; 130(6):559-64. PubMed ID: 8205254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pituitary adenomas of patients with acromegaly express thyrotropin-releasing hormone receptor messenger RNA: cloning and functional expression of the human thyrotropin-releasing hormone receptor gene.
    Yamada M; Monden T; Satoh T; Satoh N; Murakami M; Iriuchijima T; Kakegawa T; Mori M
    Biochem Biophys Res Commun; 1993 Sep; 195(2):737-45. PubMed ID: 8396925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlative studies between the presence of thyrotropin-releasing hormone (TRH) receptors and the in vitro stimulation of growth-hormone (GH) secretion in human GH-secreting adenomas.
    Le Dafniet M; Garnier P; Bression D; Brandi AM; Racadot J; Peillon F
    Horm Metab Res; 1985 Sep; 17(9):476-9. PubMed ID: 2864309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor-binding sites, present in normal human and rat pituitaries, are absent in human pituitary adenomas.
    Birman P; Michard M; Li JY; Peillon F; Bression D
    J Clin Endocrinol Metab; 1987 Aug; 65(2):275-81. PubMed ID: 3597708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific somatostatin receptors on human pituitary adenoma cell membranes.
    Ikuyama S; Nawata H; Kato K; Karashima T; Ibayashi H; Nakagaki H
    J Clin Endocrinol Metab; 1985 Oct; 61(4):666-71. PubMed ID: 2863281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of growth hormone-releasing hormone receptors in pituitary adenomas from patients with acromegaly.
    Ikuyama S; Natori S; Nawata H; Kato K; Ibayashi H; Kariya T; Sakai T; Rivier J; Vale W
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1265-71. PubMed ID: 2836473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of thyrotropin-releasing hormone and gonadotropin-releasing hormone on inositol phospholipid turnover in endocrinologically inactive pituitary adenomas and prolactinomas.
    Levy A; Lightman SL
    J Clin Endocrinol Metab; 1989 Jul; 69(1):122-6. PubMed ID: 2543687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of specific dopamine receptors on human pituitary adenomas.
    Koga M; Nakao H; Arao M; Sato B; Noma K; Morimoto Y; Kishimoto S; Mori S; Uozumi T
    Acta Endocrinol (Copenh); 1987 Apr; 114(4):595-602. PubMed ID: 3577589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition of gonadotroph adenomas in women.
    Daneshdoost L; Gennarelli TA; Bashey HM; Savino PJ; Sergott RC; Bosley TM; Snyder PJ
    N Engl J Med; 1991 Feb; 324(9):589-94. PubMed ID: 1899470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenylate cyclase of GH and ACTH producing tumors of human: activation by non-specific hormones and other bioactive substances.
    Matsukura S; Kakita T; Hirata Y; Yoshimi H; Fukase M
    J Clin Endocrinol Metab; 1977 Feb; 44(2):392-7. PubMed ID: 190256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadotroph adenomas in men produce biologically active follicle-stimulating hormone.
    Galway AB; Hsueh AJ; Daneshdoost L; Zhou MH; Pavlou SN; Snyder PJ
    J Clin Endocrinol Metab; 1990 Oct; 71(4):907-12. PubMed ID: 2119391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
    Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solubilization of receptors for thyrotropin-releasing hormone from GH4C1 rat pituitary cells: demonstration of guanyl nucleotide sensitivity.
    Sullivan NJ; Lautens LL; Tashjian AH
    Mol Endocrinol; 1987 Dec; 1(12):889-98. PubMed ID: 2856405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Presence of high-affinity binding sites for thyroliberin in human pituitary adenomas secreting prolactin].
    Le Dafniet M; Brandi AM; Bression D; Racadot J; Peillon F
    C R Seances Acad Sci III; 1983 Jan; 296(1):43-6. PubMed ID: 6301654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotropin-releasing hormone provokes abnormal follicle-stimulating hormone (FSH) and luteinizing hormone responses in men who have pituitary adenomas and FSH hypersecretion.
    Snyder PJ; Muzyka R; Johnson J; Utiger RD
    J Clin Endocrinol Metab; 1980 Oct; 51(4):744-8. PubMed ID: 6774992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.